I recently attended the 73rd American Diabetes Association (ADA) Scientific Sessions in Chicago, June 21-25 where brilliant and dedicated researchers and health care professionals from around the globe gathered to learn, share and connect. As a diabetes educator who’s been involved in the diabetes field nearly 35 years and counting, I was once again wowed by this meeting...and learned a ton!
Though tough to choose, here are my top 10 take aways from the 2013 ADA meeting - divded into Part One and Part Two:
1. DCCT/EDIC Results Heralded: A highlight of ADA was celebrating the 30 year anniversary of the landmark type 1 study, the Diabetes Control and Complications Trial. This trial was designed to answer the questions: Does good control matter? The DCCT began in 1983 and the conclusions were unveiled at the 1993 ADA meeting (I still remember the thrill of hearing the results live!). These results showed a reduction in the early stages of diabetes complications (eye, kidneys, etc.), by up to 76% compared with so-called “conventional therapy” – two shots of insulin a day.